Literature DB >> 21638247

Multidisciplinary management of vascular access for haemodialysis: from the preparation of the initial access to the treatment of stenosis and thrombosis.

C Reinhold1, P Haage, M Hollenbeck, V Mickley, J Ranft.   

Abstract

In February 2008 a multidisciplinary study group was established in Germany to improve the treatment of patients with potential vascular access problems. As one of the first results of their work interdisciplinary recommendations for the management of vascular access were provided, from the creation of the initial access to the treatment of complications. As a rule the wrist arteriovenous fistula (AVF) is the access of choice due to its lower complication rate when compared to other types of access. The AVF should be created 3 months prior to the expected start of haemodialysis to allow for sufficient maturation. Second and third choice accesses are arteriovenous grafts (AVG) and central venous catheters (CVC). Ultrasound is a reliable tool for vessel selection before access creation, and also for the diagnosis of complications in AVF and grafts. Access stenosis and thrombosis can be treated surgically and interventionally. The comparison of both methods reveals advantages and disadvantages for each. The therapeutic decision should be based on the individual patients' constitution, and also on the availability and experience of the involved specialists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21638247     DOI: 10.1024/0301-1526/a000093

Source DB:  PubMed          Journal:  Vasa        ISSN: 0301-1526            Impact factor:   1.961


  2 in total

1.  [Dyspnea on exertion, angina pectoris and loud buzzing in the right groin in an 82-year-old man].

Authors:  C Reinhold; T Lange; H Haake; B T Weis-Müller
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

2.  Comparison of the one-year patency rates of radiocephalic arteriovenous fistulas created using no-touch versus conventional technique.

Authors:  İsmail Oral Hastaoğlu; Hamdi Toköz; Ayça Özgen; Fuat Bilgen
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-01-01       Impact factor: 0.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.